Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Pfizer (PFE) and Incyte (INCY)

Stocks The Globe and Mail By The Globe and Mail 14 Oct 2026 09:46 1 min read
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Pfizer (PFE) and Incyte (INCY)

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Pfizer (PFE) and Incyte (INCY)  The Globe and Mail

Covered in this story

Call it yourself

No calls on $FDMT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on 4d Molecular Therapeutics Inc →
Read the full story on The Globe and Mail → Opens the original article on news.google.com

Summary aggregated from The Globe and Mail's public RSS feed. The full reporting belongs to The Globe and Mail — please read it on their site.